SpaceX is unlikely to generate robust returns for individuals who buy the stock at its IPO expected later this year, investors told CNBC’s “Halftime Report.”
Source: US Top News and Analysis
News Aggregation on Steroids
SpaceX is unlikely to generate robust returns for individuals who buy the stock at its IPO expected later this year, investors told CNBC’s “Halftime Report.”
Source: US Top News and Analysis